Literature DB >> 4004512

Influence of retinoids on growth and melanin content of Harding-Passey-melanoma cells in vitro and B16 transplantable melanoma in vivo.

G Drewa, D O Schachtschabel.   

Abstract

Growth cessation and cell death of exponentially proliferating Harding-Passey melanoma cells (HPM-73 line) in monolayer culture resulted in the presence of 3.3 X 10(-5) M retinal, while retinol and retinoic acid caused growth retardation at 3.3 X 10(-5) M. Also at 1 X 10(-5) M, the growth-inhibitory effect of retinal was more pronounced than that of retinol or retinoic acid. Following serum removal from the culture media, all 3 retinoids at 3.3 X 10(-6) M or 1 X 10(-5) M revealed cytotoxic effects within 3 days as demonstrated by cell loss from the substratum. Thus, the presence of serum has "protective" effects. Addition of retinal, retinoic acid or retinol at 1 X 10(-5) M to cultures in stationary growth phase did not result in cell loss during period of 6 days. C57Bl mice with B16 melanotic melanoma were i.p. injected during 10 days with retinoids (30 or 100 mcg per mouse daily). All retinoids inhibited B16 tumor growth in vivo. In this respect, retinoic acid was the most effective one. The cellular melanin content of cultured HPM-cells and of B16 melanotic melanoma in vivo was elevated after treatment with retinoids; retinal having the strongest effect.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4004512

Source DB:  PubMed          Journal:  Arch Geschwulstforsch        ISSN: 0003-911X


  2 in total

1.  The effect of butyric acid and retinoic acid on invasion and experimental metastasis of murine melanoma cells.

Authors:  T W McGarvey; S Silberman; B Persky
Journal:  Clin Exp Metastasis       Date:  1990 Sep-Oct       Impact factor: 5.150

2.  Inhibition of K1735-M2 melanoma cell invasion in vitro by retinoic acid.

Authors:  C Helige; J Smolle; G Zellnig; E Hartmann; R Fink-Puches; H Kerl; H A Tritthart
Journal:  Clin Exp Metastasis       Date:  1993-09       Impact factor: 5.150

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.